EUVIMEDObjevte EUVIMED
BeobachtungsstudieOpen access · CC BY 4.0

The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention

Odette Hart iD, Nicole Xue, Manar Khashram iD

ANZ Journal of Surgery · 2023

DOI: 10.1111/ans.18580 ↗

At a glance

Beobachtungsstudie in ANZ Journal of Surgery, 2023. Written by Odette Hart and 2 co-authors. Institution: Department of Surgery, The University of Auckland, Auckland, New Zealand. Major MEDLINE topics: Antihypertensive Agents, Peripheral Arterial Disease, Platelet Aggregation Inhibitors, Hypolipidemic Agents. Cited 3 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0). Funded by: Reg Worcester Research Scholarship 2023, Professor Philip Walker Vascular Surgery Research Scholarship 2022 and 2021, Royal Australasian College of Surgeons and the Foundation for Surgery.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Cardiovascular disease guidelines recommend that patients with established peripheral artery disease (PAD) are prescribed antihypertensive, lipid‐lowering, and antiplatelet medication to reduce cardiovascular ischaemic events. However, the prescribing of these medications for patients with PAD within New Zealand (NZ) remains undefined.

Methods

This was a retrospective observational cohort study of patients in the Midland region of NZ, that underwent PAD‐related percutaneous and surgical intervention between 1st January 2010 and 31st December 2021. Patient level data was collected. The primary outcome was prescribing of cardioprotective medications either before or within 1 year of incident procedure. Secondary outcome was overall survival.

Results

There were 2547 patients included. Antihypertensive prescription occurred in 80.7%, lipid‐lowering in 77.4% and antithrombotic in 89.9%. Concomitant ischaemic heart disease increased prescription of cardioprotective medications. Women were prescribed less lipid‐lowering medication compared to men. Māori men were prescribed less antiplatelet medication compared to non‐Māori men. On univariate analysis lipid‐lowering and antiplatelet medication showed survival advantage, while antihypertensive and anticoagulation did not. After adjustment for age, sex, end stage renal failure and presence of chronic limb‐threatening ischaemia, best medical therapy was associated with better survival (HR 0.88, 95% CI 0.79–0.98, P = 0.02).

Conclusion

This study highlights areas of deficiency in prescribing of cardioprotective medication in this high‐risk group. These could be targets for national quality improvement initiatives.

Subjects

MeSH terms (MEDLINE)

Antihypertensive AgentsPeripheral Arterial DiseasePlatelet Aggregation InhibitorsHypolipidemic AgentsFemaleHumansMaleCohort StudiesLipidsMaori PeopleRisk FactorsTreatment OutcomeCardiovascular AgentsRetrospective StudiesAustralasian PeopleProtective AgentsCardiovascular DiseasesIschemia

Author keywords

chronic limb-threatening ischemiaepidemiologyintermittent claudicationperipheral artery disease

Substances

Antihypertensive AgentsLipidsPlatelet Aggregation InhibitorsHypolipidemic AgentsCardiovascular AgentsProtective Agents

Authors and institutions

  • Department of Surgery, The University of Auckland, Auckland, New Zealand.
  • Department of Vascular Surgery, Waikato District Health Board, Hamilton, New Zealand.

ORCID profiles: Odette Hart, Manar Khashram

Funding

  • Reg Worcester Research Scholarship 2023
  • Professor Philip Walker Vascular Surgery Research Scholarship 2022 and 2021
  • Royal Australasian College of Surgeons and the Foundation for Surgery

Cite

APA

Hart, O., Xue, N., & Khashram, M. (2023). The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18580

Vancouver

Hart O, Xue N, Khashram M. The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention. ANZ Journal of Surgery. 2023. doi:10.1111/ans.18580

BibTeX
@article{Hart2023,
  author = {Hart, Odette and Xue, Nicole and Khashram, Manar},
  title = {The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention},
  journal = {ANZ Journal of Surgery},
  year = {2023},
  doi = {10.1111/ans.18580}
}
Start for free →